VivoSim Labs, Inc.

VIVS ·Healthcare, Drug Manufacturers - General, United States
Financial Statements › Balance Sheet
Annual Quarterly

Balance Sheet

Line Item FY2018 FY2017 FY2016 FY2015 FY2014 FY2013 FY2012 FY2011
Assets
Cash & Equivalents $43.7M $62.8M $62.1M $50.1M $48.2M $15.6M $14.8M $340.0K
Accounts Receivable $883.0K $647.0K $259.0K $0 — — — —
Inventory $842.0K $550.0K $334.0K $66.0K $63.0K $88.0K $360.0K $292.0K
Total Current Assets $46.8M $65.1M $63.7M $51.3M $49.2M $16.1M $15.9M $1.0M
Property, Plant & Equipment $2.8M $3.8M $3.7M $2.0M $857.0K $1.0M $714.0K —
Goodwill — — — — — — — —
Intangible Assets (Excl. Goodwill) — — — — — — — —
Total Assets $49.8M $69.2M $67.6M $53.5M $50.2M $17.4M $16.7M $1.4M
Liabilities
Accounts Payable $464.0K $1.2M $787.0K $1.4M $326.0K $641.0K $425.0K $658.0K
Total Current Liabilities $4.7M $6.0M $4.5M $4.8M $1.9M $8.4M $22.0M $2.0M
Long-Term Debt — — — — — — — —
Total Liabilities $5.2M $6.8M $5.4M $4.8M $1.9M $8.4M $22.1M $3.2M
Stockholders' Equity
Retained Earnings $-234.1M $-199.3M $-160.9M $-122.3M — — — —
Total Stockholders' Equity $44.6M $62.4M $62.2M $48.7M $48.3M $9.0M $-5.3M $-1.8M
← Newer Page 2 of 2 Older →